Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

27/07/2022 08:00

Jul 27 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               9.61                9.81             45.00    
                   (-2.1 pct)          (+89.4 pct)      (-11.9 pct) 
  Operating           1.54                2.98             14.50    
                   (-48.5 pct)        (+280.3 pct)      (-27.3 pct) 
  Recurring           2.08                3.00             14.50    
                   (-30.5 pct)        (+247.6 pct)      (-29.3 pct) 
  Net                 1.37                1.53             10.30    
                   (-10.7 pct)         (+99.8 pct)      (-29.0 pct) 
  EPS               11.06 yen           12.40 yen        83.25 yen  
  EPS Diluted       11.02 yen           12.34 yen                   
  Ann Div                               22.00 yen        20.00 yen  
  -Q2 div                               10.00 yen        10.00 yen  
  -Q4 div                               12.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T